In this report, the EMEA HER2 Antibody market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of HER2 Antibody for these regions, from 2018 to 2025 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA HER2 Antibody market competition by top manufacturers/players, with HER2 Antibody sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Genentech Inc
Novartis AG
Pfizer
Abnova Corporation
InvivoGen
Celltrion
Biocon Limited
Bio-Techne
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Trastuzumab
Lapatinib
Ado-trastuzumab Emtansine
Pertuzumab
Everolimus
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of HER2 Antibody for each application, including
Hospital
Medical Center
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) HER2 Antibody Market Report 2019
1 HER2 Antibody Overview
1.1 Product Overview and Scope of HER2 Antibody
1.2 Classification of HER2 Antibody
1.2.1 EMEA HER2 Antibody Market Size (Sales) Comparison by Type (2014-2024)
1.2.2 EMEA HER2 Antibody Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Trastuzumab
1.2.4 Lapatinib
1.2.5 Ado-trastuzumab Emtansine
1.2.6 Pertuzumab
1.2.7 Everolimus
1.3 EMEA HER2 Antibody Market by Application/End Users
1.3.1 EMEA HER2 Antibody Sales (Volume) and Market Share Comparison by Application (2014-2024
1.3.2 Hospital
1.3.3 Medical Center
1.4 EMEA HER2 Antibody Market by Region
1.4.1 EMEA HER2 Antibody Market Size (Value) Comparison by Region (2014-2024)
1.4.2 Europe Status and Prospect (2014-2024)
1.4.3 Middle East Status and Prospect (2014-2024)
1.4.4 Africa Status and Prospect (2014-2024)
1.5 EMEA Market Size (Value and Volume) of HER2 Antibody (2014-2024)
1.5.1 EMEA HER2 Antibody Sales and Growth Rate (2014-2024)
1.5.2 EMEA HER2 Antibody Revenue and Growth Rate (2014-2024)
2 EMEA HER2 Antibody Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA HER2 Antibody Market Competition by Players/Manufacturers
2.1.1 EMEA HER2 Antibody Sales Volume and Market Share of Major Players (2014-2019)
2.1.2 EMEA HER2 Antibody Revenue and Share by Players (2014-2019)
2.1.3 EMEA HER2 Antibody Sale Price by Players (2014-2019)
2.2 EMEA HER2 Antibody (Volume and Value) by Type/Product Category
2.2.1 EMEA HER2 Antibody Sales and Market Share by Type (2014-2019)
2.2.2 EMEA HER2 Antibody Revenue and Market Share by Type (2014-2019)
2.2.3 EMEA HER2 Antibody Sale Price by Type (2014-2019)
2.3 EMEA HER2 Antibody (Volume) by Application
2.4 EMEA HER2 Antibody (Volume and Value) by Region
2.4.1 EMEA HER2 Antibody Sales and Market Share by Region (2014-2019)
2.4.2 EMEA HER2 Antibody Revenue and Market Share by Region (2014-2019)
2.4.3 EMEA HER2 Antibody Sales Price by Region (2014-2019)
3 Europe HER2 Antibody (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe HER2 Antibody Sales and Value (2014-2019)
3.1.1 Europe HER2 Antibody Sales Volume and Growth Rate (2014-2019)
3.1.2 Europe HER2 Antibody Revenue and Growth Rate (2014-2019)
3.2 Europe HER2 Antibody Sales and Market Share by Type
3.3 Europe HER2 Antibody Sales and Market Share by Application
3.4 Europe HER2 Antibody Sales Volume and Value (Revenue) by Countries
3.4.1 Europe HER2 Antibody Sales Volume by Countries (2014-2019)
3.4.2 Europe HER2 Antibody Revenue by Countries (2014-2019)
3.4.3 Germany HER2 Antibody Sales and Growth Rate (2014-2019)
3.4.4 France HER2 Antibody Sales and Growth Rate (2014-2019)
3.4.5 UK HER2 Antibody Sales and Growth Rate (2014-2019)
3.4.6 Russia HER2 Antibody Sales and Growth Rate (2014-2019)
3.4.7 Italy HER2 Antibody Sales and Growth Rate (2014-2019)
3.4.8 Benelux HER2 Antibody Sales and Growth Rate (2014-2019)
4 Middle East HER2 Antibody (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East HER2 Antibody Sales and Value (2014-2019)
4.1.1 Middle East HER2 Antibody Sales Volume and Growth Rate (2014-2019)
4.1.2 Middle East HER2 Antibody Revenue and Growth Rate (2014-2019)
4.2 Middle East HER2 Antibody Sales and Market Share by Type
4.3 Middle East HER2 Antibody Sales and Market Share by Application
4.4 Middle East HER2 Antibody Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East HER2 Antibody Sales Volume by Countries (2014-2019)
4.4.2 Middle East HER2 Antibody Revenue by Countries (2014-2019)
4.4.3 Saudi Arabia HER2 Antibody Sales and Growth Rate (2014-2019)
4.4.4 Israel HER2 Antibody Sales and Growth Rate (2014-2019)
4.4.5 UAE HER2 Antibody Sales and Growth Rate (2014-2019)
4.4.6 Iran HER2 Antibody Sales and Growth Rate (2014-2019)
5 Africa HER2 Antibody (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa HER2 Antibody Sales and Value (2014-2019)
5.1.1 Africa HER2 Antibody Sales Volume and Growth Rate (2014-2019)
5.1.2 Africa HER2 Antibody Revenue and Growth Rate (2014-2019)
5.2 Africa HER2 Antibody Sales and Market Share by Type
5.3 Africa HER2 Antibody Sales and Market Share by Application
5.4 Africa HER2 Antibody Sales Volume and Value (Revenue) by Countries
5.4.1 Africa HER2 Antibody Sales Volume by Countries (2014-2019)
5.4.2 Africa HER2 Antibody Revenue by Countries (2014-2019)
5.4.3 South Africa HER2 Antibody Sales and Growth Rate (2014-2019)
5.4.4 Nigeria HER2 Antibody Sales and Growth Rate (2014-2019)
5.4.5 Egypt HER2 Antibody Sales and Growth Rate (2014-2019)
5.4.6 Algeria HER2 Antibody Sales and Growth Rate (2014-2019)
6 EMEA HER2 Antibody Manufacturers/Players Profiles and Sales Data
6.1 Genentech Inc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 HER2 Antibody Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Genentech Inc HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Novartis AG
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 HER2 Antibody Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Novartis AG HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Pfizer
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 HER2 Antibody Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Pfizer HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Abnova Corporation
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 HER2 Antibody Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abnova Corporation HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 InvivoGen
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 HER2 Antibody Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 InvivoGen HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Celltrion
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 HER2 Antibody Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Celltrion HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Biocon Limited
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 HER2 Antibody Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Biocon Limited HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Bio-Techne
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 HER2 Antibody Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bio-Techne HER2 Antibody Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
7 HER2 Antibody Manufacturing Cost Analysis
7.1 HER2 Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of HER2 Antibody
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 HER2 Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of HER2 Antibody Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA HER2 Antibody Market Forecast (2019-2024)
11.1 EMEA HER2 Antibody Sales, Revenue and Price Forecast (2019-2024)
11.1.1 EMEA HER2 Antibody Sales and Growth Rate Forecast (2019-2024)
11.1.2 EMEA HER2 Antibody Revenue and Growth Rate Forecast (2019-2024)
11.1.3 EMEA HER2 Antibody Price and Trend Forecast (2019-2024)
11.2 EMEA HER2 Antibody Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.3 Europe HER2 Antibody Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.4 Middle Eastt HER2 Antibody Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.5 Africa HER2 Antibody Sales, Revenue and Growth Rate Forecast by Region (2019-2024)
11.6 EMEA HER2 Antibody Sales Forecast by Type (2019-2024)
11.7 EMEA HER2 Antibody Sales Forecast by Application (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
